Skip to content
A197A197A197

Drawing based on the label description. No photo yet.

“250 mg, purple colored, caplet shaped, biconvex film-coated tablet imprinted in black ink with "A197" on one side and plain on other side”

A197 pill

Pill with imprint A197 is purple, capsule, 14 mm and has been identified as Lamotrigine 250 mg. It is used for bipolar disorder, seizures and focal seizures. It is supplied by Alembic Pharmaceuticals Limited.

Lamotrigine 250 mg

Imprint
A197
Strength
250 mg
Used for
Bipolar disorder, seizures and focal seizures
Color
Purple
Shape
Capsule / oblong
Size
14 mm
Score
No score line
Form
Tablet, extended release
Manufacturer
Alembic Pharmaceuticals Limited
Drug class
Mood stabilizer
NDC
46708-418, 46708-418-30, 46708-418-91, 62332-418, 62332-418-30, 62332-418-91

Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Lamotrigine pills and guides

What is Lamotrigine used for?

Lamotrigine is used for bipolar disorder, seizures and focal seizures.

Medicine type
Mood stabilizer; seizure medicine (anti-epileptic)
Official uses from the US prescribing label

Epilepsy

Adjunctive Therapy

Lamotrigine is indicated as adjunctive therapy for the following seizure types in patients aged 2 years and older:

  • partial-onset seizures.
  • primary generalized tonic-clonic (PGTC) seizures.
  • generalized seizures of Lennox-Gastaut syndrome.

Monotherapy

Lamotrigine is indicated for conversion to monotherapy in adults (aged 16 years and older) with partial-onset seizures who are receiving treatment with carbamazepine, phenytoin, phenobarbital, primidone, or valproate as the single antiepileptic drug (AED).

Safety and effectiveness of lamotrigine have not been established as initial monotherapy; for conversion to monotherapy from AEDs other than carbamazepine, phenytoin, phenobarbital, primidone, or valproate; or for simultaneous conversion to monotherapy from 2 or more concomitant AEDs.

Bipolar Disorder

Lamotrigine is indicated for the maintenance treatment of bipolar I disorder to delay the time to occurrence of mood episodes (depression, mania, hypomania, mixed episodes) in patients treated for acute mood episodes with standard therapy.

Limitations of Use

Treatment of acute manic or mixed episodes is not recommended. Effectiveness of lamotrigine in the acute treatment of mood episodes has not been established.

From the FDA-approved label on DailyMed (published Sep 28, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your pill? Check every detail

  • One side shows A197 and the other side is plain.
  • It is purple, capsule, 14 mm.
  • Its score line and coating match the details on this page.
  • It came from a pharmacy package that names the same drug.

Ingredients

Active: Lamotrigine

Inactive: Lactose Monohydrate, Povidone K30, Hypromelloses, Silicon Dioxide, Magnesium Stearate, Methacrylic Acid and Ethyl Acrylate Copolymer, Triethyl Citrate, Titanium Dioxide, Polyethylene Glycol 400, Ferrosoferric Oxide, Fd&c Blue No. 2, Cochineal, Shellac, Propylene Glycol

Also distributed by

Alembic Pharmaceuticals Inc.

Pills that look similar but are different drugs

Same color and shape, different medicine. This is why the imprint matters.

Other Lamotrigine pills